Immunovant (IMVT) Q2 2026 Earnings

20MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.73
-0.68
-0.64
-0.59

Details

Expected EPS
-0.592021
Actual EPS
-0.73
Surprise EPS
-0.14
Surprise Percent
+23.31%

Description

Immunovant (IMVT) has reported earnings of -0.73 per share for Q2 2026.

0 Comments

Share your thoughts